Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | tert-Butyl 4-formylpiperidine-1-carboxylate | HCID 1514430 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Reactant | HCID 59432300 | HCID 59432300 | — |
| Solvent | 1,2-Dichloroethane | HCID 11 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 59432385 | HCID 59432385 | — |
Reaction Steps
Add sodium triacetoxyborohydride (0.374 g, 1.76 mmol) portionwise to a solution of (S)-(3,5-bistrifluoromethylbenzyl)-(7,9-dimethyl-8-trifluoromethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-yl)-(2-methyl-2H-tetrazol-5-yl)-amine (Example 148, Step 2) (0.250 g, 0.441 mmol), tert-butyl-4-formylpiperidine-1-carboxylate (0.282 g, 1.32 mmol) and glacial acetic acid (0.2 mL) in 1,2-dichloroethane (3 mL) at room temperature under an atmosphere of nitrogen and stir for 24 h. Quench the reaction with saturated sodium bicarbonate (5 mL) and dilute with dichloromethane (15 mL). Separate the layers and wash the organic layer with saturated sodium bicarbonate and brine (20 mL each). Dry the organic layer over sodium sulfate, filter and remove the solvent under reduced pressure. Purify the residue using flash column chromatography on silica gel, eluting with hexanes/ethyl acetate (80:20), to provide the title compound as a white crushable foam (0.272 g, 81%). 1H NMR (CDCl3, 500 MHz) δ 0.87-1.14 (m, 3H), 1.24-1.34 (m, 1H), 1.45 (s, 9H), 1.61-1.97 (m, 7H), 2.30-2.33 (m, 6H), 2.65-2.75 (m, 2H), 2.86-2.89 (m, 2H), 2.95-3.11 (m, 1H), 3.25-3.28 (m, 1H), 4.13 (s, 3H), 4.81-4.88 (m, 1H), 5.21 (br s, 1H), 5.60 (br s, 1H), 6.57 (s, 1H), 7.77 (s, 3H); ESI MS m/z 764 [C35H42F9N7O2+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07786108B2 |
|---|
| Source dataset | uspto-grants-2010_08 |
|---|
| ORD ID | ord-8b17f4e6cff44806a6915fd02521fd5e |
|---|
| Source note | uspto-grants-2010_08 |
|---|